secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLIGENIX, INC. (SNGX)
CIK:        0000812796
Form:       8-K
Filed at:   2024-07-09T23:59:59+00:00
Accession:  0001558370-24-009712
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soligenix induces warrant exercise for up to $4.2M, issues new warrants at 150% coverage
--------------------------------------------------------------------------------

- Up to 703,125 existing warrants exercised at $6.00/share; gross proceeds up to ~$4.2M.
- For each exercised warrant, company issues new warrant to purchase 150% of shares, exercisable at $6.00, 5-year term.
- New warrants unregistered; company to file S-1 resale registration by July 25, 2024.
- A.G.P. receives 6% fee of gross proceeds; net proceeds for clinical development and working capital.
- Exhibit warns of potential Nasdaq delisting risk if compliance not regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/812796/000155837024009712/0001558370-24-009712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/812796/000155837024009712/sngx-20240709x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer